VTYX: SEC Form 8-K filed by Ventyx Biosciences Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for VTYX
Across the 6 sessions after earlier VTYX headlines, the stock closed higher 3 times and lower 3 times, with a median move of 8.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | VTYX | SPY |
|---|---|---|---|
| Dec 2, 2025 | Ventyx Provides Clinical and Corporate Updates | -15.4% | +0.2% |
| Dec 1, 2025 | Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference | -6.2% | -0.5% |
| Nov 17, 2025 | Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London | +2.7% | -0.9% |
| Nov 7, 2025 | Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress | -5.3% | +0.1% |
| Nov 5, 2025 | Ventyx Biosciences upgraded by H.C. Wainwright with a new price target | +11.2% | +0.3% |
| Oct 23, 2025 | Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors | +71.0% | +0.6% |
Quantisnow market dataNASDAQ
VTYX
Ventyx Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for VTYX
Full VTYX profile on Quantisnow Follow VTYX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time